Live tape
Top 8, mentions 7d8,819GOOGL1,687 mentions▲ +0.04MRNA1,338 mentions▲ +0.09SNDK1,281 mentions▲ +0.10META1,119 mentions▲ +0.03NVDA1,043 mentions▲ +0.08SPCX899 mentions▲ +0.08NBIS744 mentions▲ +0.09MSFT708 mentions▲ +0.05

Equity · Healthcare

RGEN

Repligen Corporation · NasdaqGS

$141 −2.08% 1D Finazon · prior-day close
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for RGEN to draw a line in its place.

The chart above plots the price of RGEN over the range selected — one day to the full history — drawn by TradingView from their own data.

Market cap $8.0B
P/E (TTM) 185.5
52-week range $102.85 – $172
Avg volume 410.3K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026

RGEN insider trades

SEC Form 4

RGEN has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 4 December 2025.

Date Insider Type Shares Value
25 Nov 2025 Loeillot Olivier Chief Executive Officer Sell 7,041 $1.20M
18 Nov 2025 Bylund James Chief Operating Officer Sell 2,191 $331K
13 Nov 2025 Hunt Anthony Sell 20,000 $3.09M
12 Nov 2025 Hunt Anthony Sell 25,000 $3.92M
10 Sep 2025 Hunt Anthony Sell 29,111 $3.51M
08 Aug 2025 Madaus Martin D Buy 1,800 $202K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
04 Dec 2025 Hunt Anthony Other (filer-described) 2,000
13 Nov 2025 Hunt Anthony Option exercise 2,952 $100K
12 Nov 2025 Hunt Anthony Option exercise 25,000 $847K
02 Oct 2025 Loeillot Olivier Chief Executive Officer Tax withheld 1,248 $181K
25 Sep 2025 Garland Jason K CFO Tax withheld 412 $50K
10 Sep 2025 Hunt Anthony Option exercise 20,000 $677K
03 Sep 2025 Loeillot Olivier Chief Executive Officer Tax withheld 2,506 $291K
02 Sep 2025 Hughes Violetta CHIEF ACCOUNTING OFFICER Award 8,056

RGEN reported financials

SEC EDGAR XBRL

RGEN reported revenue of $738.3M for the fiscal year ended 31 Dec 2025. Net income over the same period was $48.9M.

Figure Reported Period
Revenue $738.3M 31 Dec 2025 fiscal year
Net income $48.9M 31 Dec 2025 fiscal year
Diluted EPS $0.86 31 Dec 2025 fiscal year
Total assets $3.0B 30 Jun 2026 at period end
Total equity $2.1B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

RGEN earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.09
31 Mar 2026 Q1 2026 $0.15
31 Dec 2025 FY 2025 $0.86
30 Sep 2025 Q3 2025 $0.26
30 Jun 2025 Q2 2025 $0.26
31 Mar 2025 Q1 2025 $0.10
31 Dec 2024 FY 2024 $-0.46
30 Sep 2024 Q3 2024 $-0.01

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

RGEN institutional holders

SEC Form 13F

11 of the 45 institutional funds we track reported a RGEN position for the quarter ended 30 Jun 2026 — a combined $462.6M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
Maverick Capital Added +30.7% shares 1,984,554 $270.8M
Citadel Advisors Trimmed −65.8% shares 376,309 $51.3M
Balyasny Asset Management Added +183.3% shares 355,507 $48.5M
Marshall Wace New position 282,107 $38.5M
Point72 Asset Management Trimmed −70.8% shares 166,157 $22.7M
D. E. Shaw & Co. New position 83,328 $11.4M
Duquesne Family Office New position 77,400 $10.6M
Tudor Investment Corp New position 25,678 $3.5M
Man Group Added +81.9% shares 20,341 $2.8M
Two Sigma Investments New position 9,901 $1.4M

Showing the 10 largest of 11 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings